TSS
CKPT

Two Sigma Securities’s Checkpoint Therapeutics CKPT Stock Holding History

Two Sigma Securities’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,110
Closed -$32.3K – 3034
2023
Q4 		$32.3K Buy
+14,110
New +$30.7K ﹤0.01% 2651

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Securities's CKPT Position: Q1 2024 in Review

Two Sigma Securities sold out of Checkpoint Therapeutics (CKPT) in Q1 2024, closing a stake of 14,110 shares — an estimated $32.3K sold.

Two Sigma Securities first reported a position in CKPT in Q4 2023 and held it in 1 quarter. The position peaked at $32.3K in Q4 2023. 40 funds tracked by Wall St. Rank hold CKPT as of Q1 2024.

  • Two Sigma Securities reported no remaining Checkpoint Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 14,110 Checkpoint Therapeutics shares in Q1 2024, an estimated $32.3K.
  • Two Sigma Securities first reported a position in Checkpoint Therapeutics in Q4 2023 and held it in 1 quarter.
  • Two Sigma Securities's Checkpoint Therapeutics position peaked at $32.3K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.